COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Share repurchase programme

05/03/2018 - 14:52

Bagsværd, Denmark, 5 March 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]

Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2017 Financial Results

05/03/2018 - 14:37

DUBLIN, Ireland, March 05, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB ), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report [...]

Marrone Bio Innovations, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 6, 2018

05/03/2018 - 14:31

DAVIS, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, [...]

R1 Announces New Patient Experience Solution for the Revenue Cycle

05/03/2018 - 14:30

CHICAGO, March 05, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced the availability of its new [...]

Hemispherx to Present at the 30th Annual ROTH Conference

05/03/2018 - 14:30

ORLANDO, Fla., March 05, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, announced today that it will be presenting at the 30 th Annual ROTH Conference on [...]

International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson's Disease Clinical Trial

05/03/2018 - 14:30

CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products [...]

Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018

05/03/2018 - 14:30

WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2018 After Market Close on March 12, 2018

05/03/2018 - 14:05

TUSTIN, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]

iRestore Hair Growth System Launches Hair Gummy Vitamins for Healthier, Fuller Hair

05/03/2018 - 14:04

LOS ANGELES, March 05, 2018 (GLOBE NEWSWIRE) -- Creator of the FDA-cleared at-home iRestore Laser Hair Growth System , Freedom Laser Therapy , today launches iRestore Hair Gummy Vitamins for optimal hair health, [...]

Allscripts and Lyft partner to eliminate transportation barriers to healthcare

05/03/2018 - 14:01

LAS VEGAS, March 05, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) and Lyft, the fastest growing rideshare company in the U.S., are joining forces to incorporate non-emergency transportation directly into the [...]

Cellectar Biosciences to Present at Upcoming March Conferences

05/03/2018 - 14:00

MADISON, Wis., March 05, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the [...]

CymaBay Therapeutics to Participate in Upcoming Investor Conferences in March

05/03/2018 - 14:00

NEWARK, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Abiomed Showcases Impella® Technology that Enables Heart Recovery at ACC with 25 Presentations

05/03/2018 - 14:00

DANVERS, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support and recovery technologies, announces that there are more than 25 presentations scheduled [...]

Biotricity Announces Commercial Rollout of Proprietary Bioflux Device

05/03/2018 - 14:00

REDWOOD CITY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]

Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for Liver Metastases Demonstrates Therapeutic Activity in Stage IV Pancreas Cancer in a Phase 1b HITM-SURE Trial (NCT02850536)

05/03/2018 - 14:00

SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) (“Sorrento”), cellular therapy focused subsidiary, TNK Therapeutics, Inc. (“TNK”), and Surefire Medical, Inc., announced today [...]

Daré Bioscience, Inc. To Participate in the 30th Annual ROTH Conference

05/03/2018 - 14:00

SAN DIEGO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that Sabrina Martucci Johnson, President and Chief [...]

Epilepsy Foundation Awards $200,000 at ‘Shark Tank’ Competition for Innovative Products that Aim to Improve Epilepsy Treatment and Care

05/03/2018 - 14:00

LANDOVER, Md., March 05, 2018 (GLOBE NEWSWIRE) -- The Epilepsy Foundation announced the winners of the 2018 Shark Tank competition for innovative ideas in epilepsy and seizure treatment and care on February 22, 2018, at [...]

Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences

05/03/2018 - 14:00

CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it [...]

Genocea to Present at Two March Investor Conferences

05/03/2018 - 14:00

CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief [...]